Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 163 articles:
HTML format
Text format



Single Articles


    April 2018
  1. KANG WH, Tak E, Hwang S, Song GW, et al
    Metformin-associated Chemopreventive Effects on Recurrence After Hepatic Resection of Hepatocellular Carcinoma: From In Vitro to a Clinical Study.
    Anticancer Res. 2018;38:2399-2407.
    PubMed     Text format     Abstract available


  2. TSAI JJ, Hsu FT, Pan PJ, Chen CW, et al
    Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.
    Anticancer Res. 2018;38:2119-2125.
    PubMed     Text format     Abstract available


    March 2018
  3. TOYA R, Saito T, Shiraishi S, Kai Y, et al
    Dose-function Histogram Evaluation Using (99m)Tc-GSA SPECT/CT Images for Stereotactic Body Radiation Therapy Planning for Hepatocellular Carcinoma Patients: A Dosimetric Parameter Comparison.
    Anticancer Res. 2018;38:1511-1516.
    PubMed     Text format     Abstract available


  4. OKANO N, Kasuga A, Kawai K, Yamauchi Y, et al
    The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer.
    Anticancer Res. 2018;38:1755-1761.
    PubMed     Text format     Abstract available


  5. FILIPESCU A, Balescu I, Bacalbasa N
    Upper Abdominal Resection for Isolated Metastatic Lesions in Recurrent Cervical Cancer.
    Anticancer Res. 2018;38:1659-1663.
    PubMed     Text format     Abstract available


  6. KINOSHITA K, Beppu T, Miyata T, Kuramoto K, et al
    A Case of 15-Year Recurrence-free Survival After Microwave Coagulation Therapy for Liver Metastasis from Gastric Cancer.
    Anticancer Res. 2018;38:1595-1598.
    PubMed     Text format     Abstract available


  7. MORIS D, Ntanasis-Stathopoulos I, Tsilimigras DI, Vagios S, et al
    Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Anticancer Res. 2018;38:1267-1278.
    PubMed     Text format     Abstract available


    February 2018
  8. IMAI K, Yamashita YI, Yusa T, Nakao Y, et al
    Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation.
    Anticancer Res. 2018;38:1053-1060.
    PubMed     Text format     Abstract available


  9. TSUKAMOTO M, Yamashita YI, Imai K, Umezaki N, et al
    Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Anticancer Res. 2018;38:1047-1052.
    PubMed     Text format     Abstract available


  10. SATTLER T, Bredt C, Surwald S, Rust C, et al
    Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 mum for the Treatment of Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:1025-1032.
    PubMed     Text format     Abstract available


  11. UEMOTO K, Doi H, Shiomi H, Yamada K, et al
    Clinical Assessment of Micro-residual Tumors during Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:945-954.
    PubMed     Text format     Abstract available


  12. HORTON CE, Kamal M, Leslie M, Zhang R, et al
    Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans.
    Anticancer Res. 2018;38:1073-1076.
    PubMed     Text format     Abstract available


  13. OSADA S, Gotoh A, Yokoi R, Tsuchiya H, et al
    Effective Timing of Surgical Resection of Colorectal Cancer Liver Metastases During Chemotherapy.
    Anticancer Res. 2018;38:737-743.
    PubMed     Text format     Abstract available


  14. DOI H, Beppu N, Kitajima K, Kuribayashi K, et al
    Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Anticancer Res. 2018;38:591-599.
    PubMed     Text format     Abstract available


  15. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
    The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
    Anticancer Res. 2018;38:811-816.
    PubMed     Text format     Abstract available


    January 2018
  16. KURAMOTO K, Beppu T, Nitta H, Imai K, et al
    Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Anticancer Res. 2018;38:525-531.
    PubMed     Text format     Abstract available


  17. YOSHIMOTO T, Imura S, Morine Y, Ikemoto T, et al
    The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Anticancer Res. 2018;38:501-507.
    PubMed     Text format     Abstract available


  18. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Text format     Abstract available


  19. VIRGILIO E, Cavallini M
    Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-invasive Approaches? A Review of the Preferable Treatment Options.
    Anticancer Res. 2018;38:33-36.
    PubMed     Text format     Abstract available


    December 2017
  20. TSUKAMOTO M, Yamashita YI, Imai K, Umezaki N, et al
    Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.
    Anticancer Res. 2017;37:6971-6975.
    PubMed     Text format     Abstract available


  21. LIANG YH, Shao YY, Chen HM, Cheng AL, et al
    Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
    Anticancer Res. 2017;37:7095-7104.
    PubMed     Text format     Abstract available


  22. MIYATA T, Beppu T, Higashi T, Nakagawa S, et al
    A Glissonean Approach with Individual Isolation During Right Hemi-Hepatectomy After Portal Vein Embolization.
    Anticancer Res. 2017;37:7069-7071.
    PubMed     Text format     Abstract available


  23. SHIBATA H, Ohike N, Norose T, Isobe T, et al
    Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
    Anticancer Res. 2017;37:7063-7068.
    PubMed     Text format     Abstract available


  24. CAIVANO D, Valeriani M, Russo I, Bonome P, et al
    Stereotactic Body Radiation Therapy in Primary and Metastatic Liver Disease.
    Anticancer Res. 2017;37:7005-7010.
    PubMed     Text format     Abstract available


    November 2017
  25. BAI YC, Hsia YC, Lin YT, Chen KH, et al
    Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells.
    Anticancer Res. 2017;37:6347-6353.
    PubMed     Text format     Abstract available


  26. CIRIMBEI C, Rotaru V, Chitoran E, Pavaleanu O, et al
    Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
    Anticancer Res. 2017;37:6489-6494.
    PubMed     Text format     Abstract available


  27. SATONAKA H, Ishida K, Takai M, Koide R, et al
    (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
    Anticancer Res. 2017;37:6071-6077.
    PubMed     Text format     Abstract available


    October 2017
  28. IMURA S, Yamada S, Saito YU, Iwahashi S, et al
    miR-223 and Stathmin-1 Expression in Non-tumor Liver Tissue of Patients with Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:5877-5883.
    PubMed     Text format     Abstract available


  29. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available


  30. RATHMANN N, Kara K, Budjan J, Henzler T, et al
    Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Anticancer Res. 2017;37:5681-5685.
    PubMed     Text format     Abstract available


  31. IKEMOTO T, Shimada M, Ishikawa D, Kawashita Y, et al
    Peripheral Tr1 and Foxp3+ Treg as Markers of Recurrent Malignancies in Patients with Hepato-Biliary Pancreatic Cancers.
    Anticancer Res. 2017;37:5541-5552.
    PubMed     Text format     Abstract available


  32. KISHIMOTO S, Yasuda M, Fukushima S
    Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin.
    Anticancer Res. 2017;37:5477-5484.
    PubMed     Text format     Abstract available


    September 2017
  33. SAKABE T, Azumi J, Umekita Y, Toriguchi K, et al
    Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:4881-4888.
    PubMed     Text format     Abstract available


  34. BI YE, Zhou Y, Wang M, Li L, et al
    Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes.
    Anticancer Res. 2017;37:5207-5214.
    PubMed     Text format     Abstract available


  35. CICERO G, Lo Re G, DE Luca R, Vernuccio F, et al
    Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experience.
    Anticancer Res. 2017;37:5187-5192.
    PubMed     Text format     Abstract available


  36. DIVELLA R, Daniele A, DE Luca R, Simone M, et al
    Circulating Levels of VEGF and CXCL1 Are Predictive of Metastatic Organotropismin in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:4867-4871.
    PubMed     Text format     Abstract available


    August 2017
  37. WANG L, Liu M, Liu L, Zheng Y, et al
    MR-guided Percutaneous Biopsy of Focal Hepatic Dome Lesions with Free-hand Combined with MR Fluoroscopy Using 1.0-T Open High-field Scanner.
    Anticancer Res. 2017;37:4635-4641.
    PubMed     Text format     Abstract available


  38. GONG Z, Chi C, Huang X, Chu H, et al
    Cyclophilin A Is Overexpressed in Hepatocellular Carcinoma and Is Associated with the Cell Cycle.
    Anticancer Res. 2017;37:4443-4447.
    PubMed     Text format     Abstract available


  39. ZHANG WG, Yin XC, Liu XF, Meng KW, et al
    Puerarin Induces Hepatocellular Carcinoma Cell Apoptosis Modulated by MAPK Signaling Pathways in a Dose-dependent Manner.
    Anticancer Res. 2017;37:4425-4431.
    PubMed     Text format     Abstract available


    July 2017
  40. HARADA N, Yoshizumi T, Yamashita YI, Soejima Y, et al
    Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
    Anticancer Res. 2017;37:3763-3769.
    PubMed     Text format     Abstract available


  41. KRAUTBAUER S, Weiss TS, Wiest R, Schacherer D, et al
    Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3527-3535.
    PubMed     Text format     Abstract available


  42. HAYASHI T, Yamashita T, Okada H, Oishi N, et al
    A Novel mTOR Inhibitor; Anthracimycin for the Treatment of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3397-3403.
    PubMed     Text format     Abstract available


  43. ISHII F, Yoshida Y, Yamauchi Y, Aisu N, et al
    Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated alphabeta T-cells.
    Anticancer Res. 2017;37:3933-3939.
    PubMed     Text format     Abstract available


  44. SHIBA I, Kouzaki R, Yamada H, Endo Y, et al
    Design and Synthesis of Novel Anti-metastatic Hypoxic Cytotoxin TX-2137 Targeting AKT Kinase.
    Anticancer Res. 2017;37:3877-3883.
    PubMed     Text format     Abstract available


  45. SETO K, Sakabe T, Itaba N, Azumi J, et al
    A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Anticancer Res. 2017;37:3569-3579.
    PubMed     Text format     Abstract available


  46. NAKAMURA M, Suetsugu A, Hasegawa K, Matsumoto T, et al
    Choline-Deficient-Diet-Induced Fatty Liver Is a Metastasis-Resistant Microenvironment.
    Anticancer Res. 2017;37:3429-3434.
    PubMed     Text format     Abstract available


    June 2017
  47. WAKIYAMA S, Matsumoto M, Haruki K, Gocho T, et al
    Clinical Features and Outcome of Surgical Patients with Non-B Non-C Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3207-3213.
    PubMed     Text format     Abstract available


  48. MATSUMOTO T, Ichikawa H, Imai J, Hayashi T, et al
    Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:3183-3187.
    PubMed     Text format     Abstract available


  49. LIN CL, Chien RN, Liang KH, Ke PY, et al
    Intrahepatic HCV RNA Level and Genotype 1 Independently Associate with Hepatic Reticulon 3 Expression.
    Anticancer Res. 2017;37:2885-2891.
    PubMed     Text format     Abstract available


    May 2017
  50. MIYATA T, Yamashita YI, Yamao T, Umezaki N, et al
    Clinical Benefits of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: A Retrospective Single-institution Study.
    Anticancer Res. 2017;37:2673-2677.
    PubMed     Text format     Abstract available


  51. HASHIMOTO M, Kobayashi T, Ishiyama K, Ide K, et al
    Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.
    Anticancer Res. 2017;37:2625-2631.
    PubMed     Text format     Abstract available


  52. LU LC, Chen PJ, Yeh YC, Hsu CH, et al
    Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.
    Anticancer Res. 2017;37:2593-2599.
    PubMed     Text format     Abstract available


  53. KANAJI N, Kita N, Kadowaki N, Bandoh S, et al
    Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Anticancer Res. 2017;37:2393-2400.
    PubMed     Text format     Abstract available


  54. BARABINO M, Gatti A, Santambrogio R, Polizzi M, et al
    Intraoperative Local Ablative Therapies Combined with Surgery for the Treatment of Bilobar Colorectal Liver Metastases.
    Anticancer Res. 2017;37:2743-2750.
    PubMed     Text format     Abstract available


    April 2017
  55. MALKI A, El-Sharkawy A, El Syaed M, Bergmeier S, et al
    Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
    Anticancer Res. 2017;37:1591-1601.
    PubMed     Text format     Abstract available


  56. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  57. OTTAIANO A, Capozzi M, DE Divitiis C, VON Arx C, et al
    Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
    Anticancer Res. 2017;37:1975-1978.
    PubMed     Text format     Abstract available


  58. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available


    March 2017
  59. DE PASQUALE MD, de Ville de Goyet J, Monti L, Grimaldi C, et al
    Bevacizumab Combined with Chemotherapy in Children Affected by Hepatocellular Carcinoma: a Single-center Experience.
    Anticancer Res. 2017;37:1489-1493.
    PubMed     Text format     Abstract available


  60. ITOH S, Uchiyama H, Ikeda Y, Morita K, et al
    Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
    Anticancer Res. 2017;37:1381-1385.
    PubMed     Text format     Abstract available


  61. MARQUES LA, Semprebon SC, Sartori D, DE Fatima A, et al
    Comparison of the Effects of Monastrol and Oxomonastrol on Human Hepatoma Cell Line HepG2/C3A.
    Anticancer Res. 2017;37:1197-1204.
    PubMed     Text format     Abstract available


  62. YOSHIKAWA M, Morine Y, Ikemoto T, Imura S, et al
    Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
    Anticancer Res. 2017;37:1169-1175.
    PubMed     Text format     Abstract available


  63. KOMATSU H, Masuda T, Iguchi T, Nambara S, et al
    Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:1083-1090.
    PubMed     Text format     Abstract available


  64. TRESKA V, Fichtl J, Bruha J, Liska V, et al
    Liver Resections for Colorectal Metastases in Patients Aged Over 75 Years.
    Anticancer Res. 2017;37:1529-1533.
    PubMed     Text format     Abstract available


  65. D'ONOFRIO M, Cingarlini S, Ortolani S, Crosara S, et al
    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
    Anticancer Res. 2017;37:1305-1311.
    PubMed     Text format     Abstract available


    February 2017
  66. IKEGAMI T, Yoshizumi T, Kawasaki J, Nagatsu A, et al
    Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:891-895.
    PubMed     Text format     Abstract available


  67. FRIEDMAN P, Lai JP
    Liver Metastasis of Urothelial Carcinoma with Hepatoid Features: An Unusual Morphological Finding.
    Anticancer Res. 2017;37:801-804.
    PubMed     Text format     Abstract available


  68. CHEN YL, Huang WC, Yao HL, Chen PM, et al
    Down-regulation of RASA1 Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:781-785.
    PubMed     Text format     Abstract available


  69. ZENG H, Wu HC, Wang Q, Yang HI, et al
    Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
    Anticancer Res. 2017;37:637-644.
    PubMed     Text format     Abstract available


  70. ZHANG S, Tang D, Zang W, Yin G, et al
    Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:465-473.
    PubMed     Text format     Abstract available


  71. MAGISTRI P, Tarantino G, Ballarin R, Berretta M, et al
    The Evolving Role of Local Treatments for HCC in the Third Millennium.
    Anticancer Res. 2017;37:389-401.
    PubMed     Text format     Abstract available


  72. RYU SH, Heo SH, Park EY, Choi KC, et al
    Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-targeted Genes.
    Anticancer Res. 2017;37:607-614.
    PubMed     Text format     Abstract available


    January 2017

  73. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. General and Surgical Pathology. Volumes 1, 2, 3, 4.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    



  74. Hepatocellular Carcinoma. Diagnosis and Treatment. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


  75. SONOHARA F, Inokawa Y, Kanda M, Nishikawa Y, et al
    Association of Inflammasome Components in Background Liver with Poor Prognosis After Curatively-resected Hepatocellular Carcinoma.
    Anticancer Res. 2017;37:293-300.
    PubMed     Text format     Abstract available


  76. CHIANG IT, Chen WT, Tseng CW, Chen YC, et al
    Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
    Anticancer Res. 2017;37:161-167.
    PubMed     Text format     Abstract available


  77. NASS N, Streit S, Wybranski C, Jurgens J, et al
    Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Anticancer Res. 2017;37:87-93.
    PubMed     Text format     Abstract available


  78. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    PubMed     Text format     Abstract available


  79. RADES D, Bolm L, Schild SE, Bartscht T, et al
    Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
    Anticancer Res. 2017;37:203-206.
    PubMed     Text format     Abstract available


  80. MORIS D, Dimitroulis D, Vernadakis S, Papalampros A, et al
    Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
    Anticancer Res. 2017;37:9-14.
    PubMed     Text format     Abstract available


    December 2016
  81. YAMASHITA YI, Wang H, Kurihara T, Tsujita E, et al
    Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC.
    Anticancer Res. 2016;36:6563-6569.
    PubMed     Text format     Abstract available


  82. MA X, Wang X, Yang C, Wang Z, et al
    DANCR Acts as a Diagnostic Biomarker and Promotes Tumor Growth and Metastasis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6389-6398.
    PubMed     Text format     Abstract available


  83. TANG M, Etokidem E, Lai K
    The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:6265-6271.
    PubMed     Text format     Abstract available


    November 2016
  84. GIORGIO A, Merola MG, Montesarchio L, Merola F, et al
    Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial.
    Anticancer Res. 2016;36:6179-6183.
    PubMed     Text format     Abstract available


  85. GARNIER A, Ilmer M, Kappler R, Berger M, et al
    Therapeutic Innovations for Targeting Hepatoblastoma.
    Anticancer Res. 2016;36:5577-5592.
    PubMed     Text format     Abstract available


  86. TAK E, Hwang S, Lee HC, Ko GY, et al
    Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue.
    Anticancer Res. 2016;36:6059-6069.
    PubMed     Text format     Abstract available


    October 2016
  87. HARIMOTO N, Yoshizumi T, Shimagaki T, Nagatsu A, et al
    Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5537-5542.
    PubMed     Text format     Abstract available


  88. KORNBERG A, Witt U, Kornberg J, Ceyhan GO, et al
    Prognostic Impact of Intraoperative Blood Loss in Liver Transplant Patients with Advanced Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5355-5364.
    PubMed     Text format     Abstract available


  89. SHEN J, Yeh CC, Wang Q, Gurvich I, et al
    Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
    Anticancer Res. 2016;36:5307-5314.
    PubMed     Text format     Abstract available


  90. HIWATASHI K, Ueno S, Sakoda M, Iino S, et al
    Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5183-5188.
    PubMed     Text format     Abstract available


  91. HASS HG, Vogel U, Scheurlen M, Jobst J, et al
    Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:5087-5095.
    PubMed     Text format     Abstract available


  92. CHANG CD, Lin PY, Hsu JL, Shih WL, et al
    Ursolic Acid Suppresses Hepatitis B Virus X Protein-mediated Autophagy and Chemotherapeutic Drug Resistance.
    Anticancer Res. 2016;36:5097-5107.
    PubMed     Text format     Abstract available


  93. ALT M, Truant S, Renaud-Vantroys T, Sequier C, et al
    Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case-Control Study.
    Anticancer Res. 2016;36:5551-5555.
    PubMed     Text format     Abstract available


    September 2016
  94. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.
    Anticancer Res. 2016;36:4725-30.
    PubMed     Text format     Abstract available


  95. INOKAWA Y, Sonohara F, Kanda M, Hayashi M, et al
    Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:4639-45.
    PubMed     Text format     Abstract available


  96. NISHIMURA M, Murayama Y, Harada K, Kamada Y, et al
    Photodynamic Diagnosis of Hepatocellular Carcinoma Using 5-Aminolevulinic Acid.
    Anticancer Res. 2016;36:4569-74.
    PubMed     Text format     Abstract available


  97. KOGAME M, Nagai H, Shinohara M, Igarashi Y, et al
    Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related Liver Cirrhosis.
    Anticancer Res. 2016;36:4529-36.
    PubMed     Text format     Abstract available


  98. PIKOULIS E, Margonis GA, Andreatos N, Sasaki K, et al
    Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:4805-11.
    PubMed     Text format     Abstract available


  99. KAWAGUCHI D, Hiroshima Y, Matsuo K, Endo I, et al
    Parenchymal Congestion Is Important for Rapid Regeneration of the Future Liver Remnant Following the ALPPS Procedure.
    Anticancer Res. 2016;36:4731-8.
    PubMed     Text format     Abstract available


    August 2016
  100. BUDJAN J, Sauter EA, Morelli JN, Nolden M, et al
    Semi-automatic Volumetric Measurement of Treatment Response in Hepatocellular Carcinoma After Trans-arterial Chemoembolization.
    Anticancer Res. 2016;36:4353-8.
    PubMed     Text format     Abstract available


  101. ITOH S, Kohnoe S, Shirabe K, Yoshida D, et al
    Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in Japan.
    Anticancer Res. 2016;36:4289-92.
    PubMed     Text format     Abstract available


  102. YEH CN, Wang SY, Chen YY, Chen MH, et al
    A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2016;36:4249-58.
    PubMed     Text format     Abstract available


  103. NANASHIMA A, Izumino H, Sumida Y, Tominaga T, et al
    Relationship Between Urinary 8-hydroxydeoxyguanine (8-OHdG) Levels and Clinicopathological Findings in Hepatobiliary Malignancies.
    Anticancer Res. 2016;36:3899-903.
    PubMed     Text format     Abstract available


  104. DJAAFAR S, Dunand-Sautier I, Gonelle-Gispert C, Lacotte S, et al
    Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-gamma-inducible Chemokines.
    Anticancer Res. 2016;36:4019-32.
    PubMed     Text format     Abstract available


    July 2016
  105. ETO D, Hisaka T, Horiuchi H, Uchida S, et al
    Expression of HSP27 in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3775-9.
    PubMed     Text format     Abstract available


  106. HONDA T, Inagawa H
    Gene Expression in Lipopolysaccharide-treated Human Monocytes Following Interaction with Hepatic Cancer Cells.
    Anticancer Res. 2016;36:3699-704.
    PubMed     Text format     Abstract available


  107. DINH VY, Bhatia S, Narayanan G, Yrizarry J, et al
    Pilot Study of Intrahepatic Artery Chemotherapy in Combination with Sorafenib in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3555-63.
    PubMed     Text format     Abstract available


  108. HATOOKA M, Kawaoka T, Aikata H, Morio K, et al
    Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
    Anticancer Res. 2016;36:3523-9.
    PubMed     Text format     Abstract available


  109. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Anticancer Res. 2016;36:3515-21.
    PubMed     Text format     Abstract available


  110. SHAH BK, Kandel P, Khanal A
    Second Primary Malignancies in Hepatocellular Cancer - A US Population-based Study.
    Anticancer Res. 2016;36:3511-4.
    PubMed     Text format     Abstract available


  111. HARADA N, Maeda T, Yoshizumi T, Ikeda T, et al
    Laparoscopic Liver Resection Is a Feasible Treatment for Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Anticancer Res. 2016;36:3489-97.
    PubMed     Text format     Abstract available


  112. AKINWANDE O, Scoggins C, Martin RC
    Early Experience with 70-150 mum Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Anticancer Res. 2016;36:3413-8.
    PubMed     Text format     Abstract available


  113. SAKAMOTO T, Ishii Y, Shiba H, Furukawa K, et al
    Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production.
    Anticancer Res. 2016;36:3301-6.
    PubMed     Text format     Abstract available


  114. ELLERKAMP V, Bortel N, Schmid E, Kirchner B, et al
    Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.
    Anticancer Res. 2016;36:3363-72.
    PubMed     Text format     Abstract available


  115. PASCALE F, Ghegediban SH, Bedouet L, Namur J, et al
    bFGF Up-regulation Reduces Spontaneous Necrosis of VX2 Tumors Without Increasing Tumoral Microvascular Density.
    Anticancer Res. 2016;36:3315-20.
    PubMed     Text format     Abstract available


  116. MATSUI T, Nagata N, Hirata K, Okazaki S, et al
    Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
    Anticancer Res. 2016;36:3437-43.
    PubMed     Text format     Abstract available


    June 2016
  117. OKADA K, Kawai M, Ueno M, Hirono S, et al
    Depth of Hepatic Infiltration and Lymph Node Swelling as Factors for Considering Surgery for T2-4 Gallbladder Carcinoma Patients.
    Anticancer Res. 2016;36:3075-80.
    PubMed     Text format     Abstract available


  118. ITOH S, Yoshizumi T, Kimura K, Okabe H, et al
    Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:3029-34.
    PubMed     Text format     Abstract available


  119. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Hepatic Resection for Liver Metastases from Cervical Cancer Is Safe and May Have Survival Benefit.
    Anticancer Res. 2016;36:3023-7.
    PubMed     Text format     Abstract available


  120. CHEN YL, Chen PM, Lin PY, Hsiau YT, et al
    ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Anticancer Res. 2016;36:2983-8.
    PubMed     Text format     Abstract available


  121. KOMATSU H, Iguchi T, Masuda T, Ueda M, et al
    HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2767-73.
    PubMed     Text format     Abstract available


  122. YANG H, Ding R, Tong Z, Huang J, et al
    siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2675-82.
    PubMed     Text format     Abstract available


  123. BRADATSCH A, Kornprat P, Bacher H, Cerwenka H, et al
    The Value of Lymph Node Dissection in the Surgery of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:2993-7.
    PubMed     Text format     Abstract available


  124. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


  125. SEMAAN A, Branchi V, Marowsky AL, VON Websky M, et al
    Incidentally Detected Focal Liver Lesions - A Common Clinical Management Dilemma Revisited.
    Anticancer Res. 2016;36:2923-32.
    PubMed     Text format     Abstract available


    May 2016
  126. IGUCHI T, Komatsu H, Masuda T, Nambara S, et al
    Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:2139-44.
    PubMed     Text format     Abstract available


  127. KIM CW, Roh SA, Tak KH, Koh BM, et al
    ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
    Anticancer Res. 2016;36:2397-406.
    PubMed     Text format     Abstract available


  128. YAMAUCHI K, Kokuryo T, Yokoyama Y, Uehara K, et al
    Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
    Anticancer Res. 2016;36:2175-9.
    PubMed     Text format     Abstract available


  129. TRESKA V
    Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives.
    Anticancer Res. 2016;36:2065-71.
    PubMed     Text format     Abstract available


    April 2016
  130. NITTA H, Baba H, Sugimori K, Furuse J, et al
    Chemotherapy-induced Nausea and Vomiting in Patients with Hepatobiliary and Pancreatic Cancer Treated with Chemotherapy: A Prospective Observational Study by the CINV Study Group of Japan.
    Anticancer Res. 2016;36:1929-35.
    PubMed     Text format     Abstract available


  131. HIROSHIMA Y, Matsuo K, Kawaguchi D, Kikuchi Y, et al
    Modified Liver Hanging Maneuver for En-bloc Right-sided Hepatectomy Combined with Total Caudate Lobectomy for Colon-Cancer Liver Metastasis and Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:1729-35.
    PubMed     Text format     Abstract available


  132. UMEHARA M, Umehara Y, Takahashi K, Murata A, et al
    Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
    Anticancer Res. 2016;36:1949-54.
    PubMed     Text format     Abstract available


  133. FICHTL J, Treska V, Lysak D, Mirka H, et al
    Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
    Anticancer Res. 2016;36:1901-7.
    PubMed     Text format     Abstract available


  134. KAIBORI M, Matsui K, Ishizaki M, Iida H, et al
    Intraoperative Detection of Superficial Liver Tumors by Fluorescence Imaging Using Indocyanine Green and 5-aminolevulinic Acid.
    Anticancer Res. 2016;36:1841-9.
    PubMed     Text format     Abstract available


  135. BACALBASA N, Taras C, Orban C, Iliescu L, et al
    Atypical Right Hepatectomy for Liver Metastasis from Ovarian Leiomyosarcoma - A Case Report and Literature Review.
    Anticancer Res. 2016;36:1835-40.
    PubMed     Text format     Abstract available


  136. NISMAN B, Appelbaum L, Yutkin V, Nechushtan H, et al
    Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver.
    Anticancer Res. 2016;36:1791-7.
    PubMed     Text format     Abstract available


  137. MATSUMOTO T, Suetsugu A, Hasegawa K, Nakamura M, et al
    Color-Coded Imaging of Syngeneic Orthotopic Malignant Lymphoma Interacting with Host Stromal Cells During Metastasis.
    Anticancer Res. 2016;36:1473-8.
    PubMed     Text format     Abstract available


    March 2016
  138. WANG LG, Jiang WJ, Fan WJ, Zheng YB, et al
    Microwave Ablation: The Differences Between Biliary Cirrhosis and Normal Porcine Liver Using a Cooled-tip Electrode.
    Anticancer Res. 2016;36:1221-6.
    PubMed     Text format     Abstract available


    February 2016
  139. KIMURA K, Itoh S, Kurihara T, Yoshida Y, et al
    Predictors of Benign Status in Liver Tumors Under 3 cm in Diameter Misdiagnosed as Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:793-7.
    PubMed     Text format     Abstract available


  140. BARA T JR, Gurzu S, Jung I, Muresan M, et al
    Giant Cavernous Hepatic Hemangioma Diagnosed Incidentally in a Perimenopausal Obese Female with Endometrial Adenocarcinoma: A Case Report.
    Anticancer Res. 2016;36:769-72.
    PubMed     Text format     Abstract available


  141. WUBETU GY, Morine Y, Teraoku H, Yoshikawa M, et al
    High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Anticancer Res. 2016;36:757-62.
    PubMed     Text format     Abstract available


  142. DAVAADORJ M, Imura S, Saito YU, Morine Y, et al
    Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Anticancer Res. 2016;36:659-64.
    PubMed     Text format     Abstract available


  143. MIYAMOTO Y, Sakamoto Y, Ohuchi M, Tokunaga R, et al
    Orbital Apex Syndrome Caused by Invasive Aspergillosis as an Adverse Effect of Systemic Chemotherapy for Metastatic Colorectal Cancer: a Case Report.
    Anticancer Res. 2016;36:821-3.
    PubMed     Text format     Abstract available


  144. KUCERA R, Topolcan O, Fiala O, Kinkorova J, et al
    The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Anticancer Res. 2016;36:773-7.
    PubMed     Text format     Abstract available


    January 2016
  145. YOSHIZUMI T, Harimoto N, Itoh S, Okabe H, et al
    Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era.
    Anticancer Res. 2016;36:439-45.
    PubMed     Text format     Abstract available


  146. UCHIYAMA H, Minagawa R, Itoh S, Kajiyama K, et al
    Favorable Outcomes of Hepatectomy for Ruptured Hepatocellular Carcinoma: Retrospective Analysis of Primary R0-Hepatectomized Patients.
    Anticancer Res. 2016;36:379-85.
    PubMed     Text format     Abstract available


  147. SHASTRI A, Msaouel P, Montagna C, White S, et al
    Primary Hepatic Small Cell Carcinoma: Two Case Reports, Molecular Characterization and Pooled Analysis of Known Clinical Data.
    Anticancer Res. 2016;36:271-7.
    PubMed     Text format     Abstract available


  148. AKINWANDE O, Philips P, Scoggins C, Martin RC, et al
    Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study.
    Anticancer Res. 2016;36:239-46.
    PubMed     Text format     Abstract available


  149. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  150. SHIRABE K, Sugimachi K, Harada N, Kayashima H, et al
    Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
    Anticancer Res. 2015;35:6963-9.
    PubMed     Text format     Abstract available


  151. SATO S, Tanaka K, Nojiri K, Kumamoto T, et al
    Hepatic Resection for Hepatocellular Carcinoma in the Elderly: Selecting Hepatectomy Procedures Based on Patient Age.
    Anticancer Res. 2015;35:6855-60.
    PubMed     Text format     Abstract available


  152. IWASE Y, Nakayama M, Yamato M, Okano T, et al
    A Biomimicking Tumor Tissue Model Using Hepatocellular Carcinoma Cell Sheet in a Collagen Sandwich System.
    Anticancer Res. 2015;35:6481-6.
    PubMed     Text format     Abstract available


  153. ENOMOTO H, Nakamura H, Liu W, Iwata Y, et al
    Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
    Anticancer Res. 2015;35:6475-9.
    PubMed     Text format     Abstract available


  154. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
    Anticancer Res. 2015;35:6919-23.
    PubMed     Text format     Abstract available


  155. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    Long-term Survivors After Liver Resection for Breast Cancer Liver Metastases.
    Anticancer Res. 2015;35:6913-7.
    PubMed     Text format     Abstract available


  156. BACALBASA N, Balescu I, Dima S, Popescu I, et al
    The Role of Re-resection for Breast Cancer Liver Metastases-a Single Center Experience.
    Anticancer Res. 2015;35:6877-80.
    PubMed     Text format     Abstract available


    November 2015
  157. SUETSUGU A, Hiroshima Y, Matsumoto T, Hasagawa K, et al
    Recruitment of Cancer-Associated Fibroblasts and Blood Vessels by Orthotopic Liver Tumors Imaged in Red Fluorescent Protein (RFP) Transgenic Nude Mice.
    Anticancer Res. 2015;35:5821-5.
    PubMed     Text format     Abstract available


  158. ANDO K, Oki E, Saeki H, Kasagi Y, et al
    Number of Lymph Node Metastases May Indicate the Regimen for Adjuvant Chemotherapy in Patients with Stage III Colorectal Cancer.
    Anticancer Res. 2015;35:6207-11.
    PubMed     Text format     Abstract available


  159. MATSUMOTO H, Okumura H, Murakami H, Kubota H, et al
    Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer.
    Anticancer Res. 2015;35:6193-9.
    PubMed     Text format     Abstract available


  160. YAMADA M, Iihara H, Fujii H, Ishihara M, et al
    Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients.
    Anticancer Res. 2015;35:6175-81.
    PubMed     Text format     Abstract available


    October 2015
  161. URATANI R, Toiyama Y, Shimura T, Mori K, et al
    Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer.
    Anticancer Res. 2015;35:5639-48.
    PubMed     Text format     Abstract available


  162. SASAKI Y, Osada S, Matsui S, Imai H, et al
    Preoperative Chemotherapy Can Change the Surgical Procedure for Hepatectomy in Patients with Liver Metastasis of Colorectal Cancer.
    Anticancer Res. 2015;35:5485-9.
    PubMed     Text format     Abstract available


  163. GIUSCA SE, Caruntu ID, Cimpean AM, Avadanei RE, et al
    Tryptase-positive and CD117 Positive Mast Cells Correlate with Survival in Patients with Liver Metastasis.
    Anticancer Res. 2015;35:5325-31.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: